Verona Pharma PLC Holding(s) in Company (5192E)

TIDMVRP

RNS Number : 5192E

Verona Pharma PLC

08 May 2017

 
 
  TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i) 
------------------------------------------------------------------------------------------ 
 
 1. Identity of the issuer or                              Verona Pharma plc 
  the underlying issuer 
  of existing shares to which 
  voting rights are 
  attached: 
--------------------------------------------------------  -------------------------------- 
 2 Reason for the notification (please tick the appropriate 
  box or boxes): 
------------------------------------------------------------------------------------------ 
 An acquisition or disposal of voting rights                             ü 
------------------------------------------------------------  ---------------------------- 
 An acquisition or disposal of qualifying financial 
  instruments which may result in the acquisition 
  of shares already issued to which voting rights 
  are attached 
------------------------------------------------------------  ---------------------------- 
 An acquisition or disposal of instruments with 
  similar economic effect to qualifying financial 
  instruments 
------------------------------------------------------------  ---------------------------- 
 An event changing the breakdown of voting rights 
------------------------------------------------------------  ---------------------------- 
 Other (please specify): 
----------------------------------------------------  ------  ---------------------------- 
 3. Full name of person(s)                               Growth Equity Opportunities 
  subject to the                                          IV, LLC 
  notification obligation: 
------------------------------------------------------  ---------------------------------- 
 4. Full name of shareholder(s) 
  (if different from 3.): 
------------------------------------------------------  ---------------------------------- 
 5. Date of the transaction                              May 2, 2017 
  and date on 
  which the threshold is 
  crossed or 
  reached: 
------------------------------------------------------  ---------------------------------- 
 6. Date on which issuer                                 May 5, 2017 
  notified: 
------------------------------------------------------  ---------------------------------- 
 7. Threshold(s) that is/are                             8% to 9% change at direct 
  crossed or                                              interest level 
  reached: 
------------------------------------------------------  ---------------------------------- 
 
 
 
 8. Notified details: 
---------------------------------------------------------------------------------------------------------------------- 
 A: Voting rights attached to shares 
---------------------------------------------------------------------------------------------------------------------- 
 Class/type     Situation previous                Resulting situation after the 
  of             to the triggering                 triggering transaction 
  shares         transaction 
 
  if possible 
  using 
  the ISIN 
  CODE 
-------------  --------------------------------  --------------------------------------------------------------------- 
                Number           Number           Number          Number of                   % of voting 
                 of               of               of shares       voting                      rights 
                 Shares           Voting                           rights 
                                  Rights 
-------------  ---------------  ---------------  --------------  --------------------------  ------------------------- 
                                                  Direct          Direct        Indirect      Direct        Indirect 
-------------      -----------    -----------    --------------  ------------  ------------  ------------  ----------- 
 Ordinary 
 Shares 
 
 GB00B06GSH43   4,424,065        4,424,065        4,424,065       4,424,065                   4.47% 
               ---------------  ---------------  --------------  ------------  ------------  ------------  ----------- 
 
 US9250501064                                     5,333,328       5,333,328                   5.39% 
-------------  ---------------  ---------------  --------------  ------------  ------------  ------------  ----------- 
 
 B: Qualifying Financial Instruments 
---------------------------------------------------------------------------------------------------------------------- 
 Resulting situation after the triggering transaction 
---------------------------------------------------------------------------------------------------------------------- 
 Type of            Expiration     Exercise/                        Number of voting              % of voting 
 financial           date           Conversion                       rights that                   rights 
 instrument                         Period                           may be 
                                                                     acquired if 
                                                                     the 
                                                                     instrument 
                                                                     is 
                                                                     exercised/ 
                                                                     converted. 
-----------------  -------------  -------------------------------  ----------------------------  --------------------- 
 
 
 C: Financial Instruments with similar economic effect 
  to Qualifying Financial Instrument 
---------------------------------------------------------------------------------------------------------------------- 
 Resulting situation after the triggering transaction 
---------------------------------------------------------------------------------------------------------------------- 
 Type of          Exercise       Expiration     Exercise/         Number of voting              % of voting 
 financial         price         date           Conversion         rights instrument             rights 
 instrument                                     period             refers to 
---------------  -------------  -------------  ----------------  ----------------------------  ----------------------- 
                                                                                                Nominal       Delta 
---------------  -------------  -------------  ----------------  ----------------------------  ------------  --------- 
 
 
 Total (A+B+C) 
---------------------------------------------------------------------------------------------------------------------- 
 Number of voting rights                            Percentage of voting rights 
-------------------------------------------------  ------------------------------------------------------------------- 
 9,757,393                                          9.86% 
-------------------------------------------------  ------------------------------------------------------------------- 
 
 
 
 9. Chain of controlled undertakings through which the 
  voting rights and/or the 
  financial instruments are effectively held, if applicable: 
----------------------------------------------------------------------------------------------- 
 
                                     Growth Equity Opportunities IV, LLC is a limited liability 
                                         company formed in the State of Delaware, United States 
                                      New Enterprise Associates 15, L.P., a limited partnership 
                                            formed in the State of Delaware, is its sole member 
                                            NEA Partners 15, L.P., a limited partnership formed 
                                               in the State of Delaware, is its general partner 
                                          NEA 15 GP, LLC, a limited liability company formed in 
                                                  the State of Delaware, is its general partner 
 
 Proxy Voting: 
----------------------------------------------------------------------------------------------- 
 10. Name of the proxy holder: 
--------------------------------------------------------------  ------------------------------- 
 11. Number of voting rights proxy 
  holder will cease 
  to hold: 
--------------------------------------------------------------  ------------------------------- 
 12. Date on which proxy holder will 
  cease to hold 
  voting rights: 
--------------------------------------------------------------  ------------------------------- 
 
 
  13. Additional information:                                    Figures are based on a total 
                                                                 number of 99,014,164 Ordinary 
                                                                 Shares outstanding, as per 
                                                                 the Company's Announcement 
                                                                 of May 2, 2017. 
--------------------------------------------------------------  ------------------------------- 
 14. Contact name:                                               Louis Citron, New Enterprise 
                                                                  Associates 
--------------------------------------------------------------  ------------------------------- 
 15. Contact telephone number:                                   [phone] 
--------------------------------------------------------------  ------------------------------- 
 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

HOLUGUBPAUPMGQR

(END) Dow Jones Newswires

May 08, 2017 12:33 ET (16:33 GMT)